Edetic Acid

Edetic Acid

SCHEMBL3846372

O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O.O=C1CCC(=O)N1O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.56
EYA2 O00167 1/20 0.56
APP P05067 1/20 0.56
ACE P12821 1/20 0.56
BLM P54132 2/20 0.54
PMP22 Q01453 2/20 0.54
KDM4E B2RXH2 1/20 0.54
LMNA P02545 1/20 0.54
CHRM2 P08172 1/20 0.54
ADRA2A P08913 1/20 0.54
ALOX15 P16050 1/20 0.54
TSHR P16473 1/20 0.54
DRD1 P21728 1/20 0.54
SLC6A2 P23975 1/20 0.54
SLC6A4 P31645 1/20 0.54
CYP2C19 P33261 1/20 0.54
ADRA1A P35348 1/20 0.54
DRD3 P35462 1/20 0.54
SLC6A3 Q01959 1/20 0.54
HRH3 Q9Y5N1 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27905518 0.80 KDM4E (0.33) TDP1EYA2APPACEKDM4E
Bromoacetic Acid SCHEMBL1064789 0.79 TSHR (0.48) LMNATSHRCA1CA12CA9
Succinic Acid SCHEMBL28916613 0.76 LMNA (0.45) PMP22KDM4ELMNATSHRCA1
Succinic Acid SCHEMBL722926 0.76 LMNA (0.45) PMP22KDM4ELMNATSHRCA1
Bicarbonate SCHEMBL14917 0.75 CA1 (0.38) KDM4ELMNATSHRCA1CA2
Bicarbonate SCHEMBL6150295 0.75 CA1 (0.38) KDM4ELMNATSHRCA1CA2
Edetic Acid SCHEMBL8607480 0.75 TDP1 (1.00) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL15136 0.75 TDP1 (1.00) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL8624198 0.75 TDP1 (1.00) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL16714076 0.75 TDP1 (1.00) TDP1EYA2APPACEBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846019-B2 Use of protoberberines as an active substance regulating the pilosebaceous unit SEDERMA (FR) 2014-09-30 US disclosed
US-20090269395-A1 USE OF PROTOBERBERINES AS AN ACTIVE SUBSTANCE REGULATING THE PILOSEBACEOUS UNIT SEDERMA (FR) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090269395-A1 USE OF PROTOBERBERINES AS AN ACTIVE SUBSTANCE REGULATING THE PILOSEBACEOUS UNIT BROX, CUTA, SHH TDP1 4382/4885EYA2 1940/4885APP 1090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.